Loading…
Enveric Biosciences, Inc. is projected to decline to $1.48 by 2027, a -8% move from its current price of $1.60. ENVB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.53 | $1.60 | $1.67 | -0.05% |
| Aug 6 | $1.51 | $1.60 | $1.70 | -0.10% |
| Aug 7 | $1.48 | $1.60 | $1.72 | -0.15% |
| Aug 8 | $1.47 | $1.60 | $1.74 | -0.20% |
| Aug 9 | $1.45 | $1.60 | $1.75 | -0.25% |
| Aug 10 | $1.44 | $1.60 | $1.77 | -0.30% |
| Aug 11 | $1.43 | $1.59 | $1.78 | -0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.43 | $1.59 | $1.78 | -0.35% |
| Week 2 | $1.36 | $1.59 | $1.86 | -0.71% |
| Week 3 | $1.30 | $1.58 | $1.92 | -1.06% |
| Week 4 | $1.26 | $1.58 | $1.97 | -1.41% |
| Week 5 | $1.22 | $1.57 | $2.02 | -1.76% |
| Week 6 | $1.19 | $1.57 | $2.06 | -2.11% |
| Week 7 | $1.16 | $1.56 | $2.10 | -2.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enveric Biosciences, Inc. is a biotechnology company focused on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Enveric Biosciences, Inc. trades with the ENVB symbol. The current price is $1.57 and the market capitalization is $6.32M, with a rank of 5210.
The forecast suggests a path of gradual upside over the coming years, starting with a 2026 average near $1.57 and moving higher in subsequent years (2029 avg $2.01, 2030 avg $2.03, 2034 avg $2.12, 2035 avg $2.53, 2040 avg $2.76, 2050 avg $4.30). ROIs vary by year, including 2029 ROI 27.9 and 2030 ROI 29.1, reflecting potential upside even as some years show more modest or negative returns (e.g., 2027 ROI -7.6). The longer horizon includes bullish sentiment in 2029, 2030, 2034, 2035, 2040, and 2050.
A major floor 26.9% below — a decisive break under it would weaken the trend.
The nearest floor, 20.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.9% away) — a breakout level to watch.
A major ceiling 232.5% above — clearing it would confirm fresh momentum.
Key ENVB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENVB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.40 | Buy | $1.43 | Buy |
| MA 10 | $1.35 | Buy | $1.39 | Buy |
| MA 20 | $1.37 | Buy | $1.40 | Buy |
| MA 50 | $1.58 | Buy | $1.65 | Sell |
| MA 100 | $2.10 | Sell | $2.84 | Sell |
| MA 200 | $3.44 | Sell | $45.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.38 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 232.88 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 18.94 | Buy |
| Bollinger %B (20,2) | 1.21 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.86 | Sell |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 76.81 | Sell |
| Momentum (10) | 0.23 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 1.45 | Buy |
| ADX (14) | 23.83 | Buy |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is generally neutral. The sentiment is NEUTRAL with RSI14 at 60. The 50-day simple moving average is $1.58 and the 200-day simple moving average is $3.44.
Support is at $1.27 and resistance at $1.57. The 30-day price range is $1.19 to $2.08, indicating a relatively tight window around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.27 | $1.60 | $1.96 | 0% | Neutral | |
| $1.12 | $1.48 | $2.09 | -8% | Neutral | |
| $1.22 | $1.68 | $2.52 | +5% | Neutral | |
| $1.43 | $2.05 | $3.19 | +28% | Bullish | |
| $1.39 | $2.06 | $3.33 | +29% | Bullish | |
| $1.21 | $1.86 | $3.10 | +16% | Neutral | |
| $1.14 | $1.80 | $3.07 | +12% | Neutral | |
| $1.06 | $1.73 | $3.01 | +8% | Neutral | |
| $1.28 | $2.15 | $3.85 | +35% | Bullish | |
| $1.50 | $2.58 | $4.70 | +61% | Bullish | |
| $1.44 | $2.81 | $5.57 | +76% | Bullish | |
| $1.98 | $4.39 | $9.77 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.27 | $1.60 | $1.94 | +0.00% |
| September 2026 | $1.26 | $1.51 | $1.88 | -5.68% |
| October 2026 | $1.26 | $1.53 | $1.93 | +1.23% |
| November 2026 | $1.29 | $1.58 | $2.03 | +3.59% |
| December 2026 | $1.22 | $1.51 | $1.96 | -4.83% |
Click any year to see its month-by-month ENVB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ENVB to range from $1.27 to $1.96 through 2026. The $1.60 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ENVB price prediction for 2027 points to an average of $1.48 (low $1.12, high $2.09) — a potential decline of -8% on today's $1.60. A consolidation phase looks the most probable path here.
In 2028, ENVB is projected to trade between $1.22 and $2.52, averaging $1.68 — a potential gain of +5% from today's $1.60. That is up +14% on the projected 2027 average. Price action looks broadly range-bound.
Enveric Biosciences, Inc.'s 2029 outlook centres on $2.05, within a $1.43 to $3.19 range. That is up +22% on the projected 2028 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ENVB could reach as high as $3.33, with a base case around $2.06 and support toward $1.39 — roughly +29% from $1.60. Momentum favours further upside here.
Expect ENVB to range from $1.21 to $3.10 through 2031. The $1.86 average target implies a +16% move from current prices. That is -10% versus the projected 2030 average. A consolidation phase looks the most probable path here.
The ENVB price prediction for 2032 points to an average of $1.80 (low $1.14, high $3.07) — a potential gain of +12% on today's $1.60. Price action looks broadly range-bound.
In 2033, ENVB is projected to trade between $1.06 and $3.01, averaging $1.73 — a potential gain of +8% from today's $1.60. That is -4% versus the projected 2032 average. A consolidation phase looks the most probable path here.
Enveric Biosciences, Inc.'s 2034 outlook centres on $2.15, within a $1.28 to $3.85 range. That is up +25% on the projected 2033 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2035, ENVB could reach as high as $4.70, with a base case around $2.58 and support toward $1.50 — roughly +61% from $1.60. Buyers look set to stay in control over this stretch.
Expect ENVB to range from $1.44 to $5.57 through 2040. The $2.81 average target implies a +76% move from current prices. That is up +9% on the projected 2035 average. Momentum favours further upside here.
The ENVB price prediction for 2050 points to an average of $4.39 (low $1.98, high $9.77) — a potential gain of +174% on today's $1.60. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENVB today (≈ 625 ENVB) could be worth
$2,743.27
+$1,743.27 (+174%) by 2050 · US Dollar
Based on the average projected ENVB price of $4.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENVBwould be worth at today's price.
$1,000 invested in ENVB on Jul 31, 2025 (≈ 68.306009 ENVB) would be worth
$109.29
-$890.71 (-89.1%) today · 0.11× · US Dollar
Based on a ENVB entry price of $14.64 vs. today's $1.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.29 | $1,240.31 | +24.0% |
| 1 month ago | $1.5 | $1,066.67 | +6.7% |
| 3 months ago | $3.99 | $401 | -59.9% |
| 6 months ago | $2.91 | $549.83 | -45.0% |
| 1 year ago | $14.64 | $109.29 | -89.1% |
| All time (5.0y) ago | $257,850 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENVB forecast.
Our base-case forecast reaches $3.20 around 2050.
Implied market cap at $3.20: $12.89M
The multi-year forecast shows a path toward higher price levels in several later years. In 2026 the average is $1.57 with a 0 ROI; 2027’s average is $1.45 with a -7.6 ROI; 2028’s average is $1.65 with a 5.4 ROI. By 2029 the average reaches $2.01 with a 27.9 ROI, and 2030 it rises to $2.03 with a 29.1 ROI, both described as BULLISH in sentiment.
Further out, 2034 carries an average of $2.12 with a 34.8 ROI and 2035 an average of $2.53 with a 61 ROI, followed by 2040 at $2.76 average with a 76 ROI and 2050 at $4.30 average with a 173.7 ROI. These years are labeled BULLISH. The forecast also shows neutral years (e.g., 2026, 2027, 2031–2033) and higher volatility, with an annualized volatility of 80%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.03 with a maximum of $3.27 and an ROI of 29.1, with sentiment BULLISH.
Forecasts show a mix of outcomes, including a 0 ROI in 2026, a -7.6 ROI in 2027, and bullish years with ROIs of 27.9 (2029), 29.1 (2030), 34.8 (2034), 61 (2035), 76 (2040), and 173.7 (2050). These are estimates and subject to risk and uncertainty.
Yes, the maximums in the forecast include $5.47 in 2040 and $9.56 in 2050, with the 2050 max reaching $9.56, indicating potential to exceed $5 over the long term, though this is not guaranteed.
The current price is $1.57.
The 2029 average is $2.01 with a maximum of $3.13 and a minimum of $1.40; ROI is 27.9 and sentiment is BULLISH.
Enveric Biosciences, Inc. Community Discussion
0Share your Enveric Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.